language_icon
EN
HI

Caplin Point Laboratories Share price

CAPLIPOINT

1709

0.00 (0.00%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:52 IST
Today's High

1725.00

Today's Low

1678.40

52 Week Low

1500.30

52 Week High

2395.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Caplin Point Laboratories Chart

Caplin Point Laboratories Share Key Metrics

Volume
56199.00
Market Cap
12990.40 CR
LTQ@LTP
9@1709.00
ATP
1700.83
Var Margin
17.84 %
Circuit Range
1382.1-2073.1
Delivery %
56.22 %
Value
9.56 CR
ASM/GSM
No
Market Lot
1

Summary

Caplin Point Laboratories share price stands at ₹1709 at 30 Apr, 2026 | 15:52. The stock Caplin Point Laboratories intraday movement has stayed between ₹1678.40 and ₹1725.00, while on a 52-week basis it has fluctuated from ₹1500.30 to ₹2395.00.
In terms of trading activity, Caplin Point Laboratories has recorded a volume of 56199 shares. The Caplin Point Laboratories has a market cap of ₹76011696. The stock’s Average Traded Price (ATP) stands at ₹170083, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9, 170900.
The Caplin Point Laboratories operates within a circuit range of ₹1382.1-2073.1 – ₹1382.1-2073.1, with a Value of ₹9.56 CR. The Delivery Percentage for the day is 56.22%. Additionally, Caplin Point Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Caplin Point Laboratories Fundamentals

View More
P/E Ratio

21.37

P/B Ratio

3.94

Div. Yield

0.35

Sector P/E

64.93

Sector P/B

3.52

Sec. Div. Yield

0.57

Caplin Point Laboratories Resistance and Support

Pivot 1704.13

Resistance

First Resistance

1729.86

Second Resistance

1750.73

Third Resistance

1776.46

Support

First Support

1683.26

Second Support

1657.53

Third Support

1636.66

Caplin Point Laboratories Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

70.57%

Mutual Fund

2.02%

Insurance

0.01%

Foreign Institutional Investors

6.15%

Domestic Institutional Investors

0.11%

Retail

21.14%

Others

0%

Total Promoters
MAR '26
70.57%

Caplin Point Laboratories Corporate Actions

DateAgenda
2026-02-05Quarterly Results
2025-11-06Quarterly Results
2025-11-05Quarterly Results
2025-08-07Quarterly Results
2025-05-15Audited Results & Interim Dividend
2025-02-07Quarterly Results

Caplin Point Laboratories News

Caplin Point Laboratories Limited

Caplin Point Laboratories filed its Q4 FY26 shareholding pattern. The promoter and promoter group collectively hold 70.57% of total shares, while public shareholding is 29.43%. Mutual funds hold 0.0202% of the company's shares.
Apr 21 2026 14:04:00

About Caplin Point Laboratories

NSE : 3906  
BSE : 524742  
ISIN : INE475E01026  

The Company was incorporated on 16th April 1990 under the Act as a Private Limited Company under the name of CAPLIN POINT LABORATORIES PRIVATE LIMITED. The name of the Company was changed to CAPLIN POINT LABORATORIES LIMITED effective 23rd April 1993. The Company has adopted a new set of Articles on 12th March 1993 as applicable to public limited companies.The Company was incorporated as an extension of a pharmaceutical manufacturing unit started by M/s Triwin Pharmaceuticals the first pharmaceutical venture started by Mr. P C Partheeban (presently the Managing Director) Mr. T Palanisamy and Mr. S Karunakaran in the year 1987 as a partnership firm. In the year 1990 the Company was incorporated by the partners of the aforesaid firm alongwith Mr. B A Ahmed. Soon thereafter Mr. S Jayaraman joined the Board to take charge of production. Recently the Board has been recast with all Directors except Mr.P.C.Partheeban making room for broadbasing the Board. The resigning Directors have taken positions as Senior level Managers in the Company.M/s Triwin Pharmaceuticals was engaged in the business of manufacture of Tablets Liquid orals and Capsules (Non-Antibiotic) and Import Sales of family planning andcertain life saving drugs. The said firm also started theExport of manufactured formulations in the year 1992-93.Even after the incorporation of the Company the firm continued its manufacturing sales and export of Tablets Liquid orals and Capsules (Non-Antibiotic) and business of import sales while the Company started the manufacture of Ointments Oral Powders and Capsules (Antibiotic).The said firm has since been taken over by the Company with effect from 1st September 1993 with the objective of consolidation of the business of the Company into a single larger entity for setting up the Project envisaged. All the assets and liabilities of the firm were taken over at book values as at 31st August 1993. The Company''s turnover in future shall comprise of the sales generated from the manufacturing faculties of the erstwhile firm also. Salient terms of the takeover Agreement executed by the Company with M/s. Triwin Pharmacuticals (''Triwin'') are as follows.a. Transfer and vesting of assets and liabilities of Triwin in the Company All the assets and liabilities of Triwin including itsfactory located at No. 44 Kamakoti Nagar AnnexeValasaravakkam Madras 600 087 on going business basis aretransferred at book values as on 31st August 1993.b. Net consideration for the transfer of assets and liabilities Consideration payable by the Company shall be the net worthof Triwin (excluding good will) estimated at Rs.3162000on the basis of its audited accounts as at 31st August1993.c. Continuance of Business In the post-transfer stage the Company to continue to dothe business then carried on by Triwin (including themanufacturing operation) and Triwin shall suspend all theproduction/sales activities hitherto carried on by them.d. Discharge of Purchase consideration The Company to issue at par its Shares credited as fullypaid-up to the partners of Triwin for an aggregate nominalvalue of Rs. 3162000 (Rupees Thirty One lacs Sixty TwoThousand only) in the proportion of amounts lying to thecredit of the respective capital/current accounts as on 31st August 1993.

Read More

Caplin Point Laboratories Management

NamePosition
G VenkatramGeneral Counsel & Company Secretary, Compliance Officer
C C PaarthipanChairman
View More

Caplin Point Laboratories FAQs

The Buying Price of Caplin Point Laboratories share is 1709 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Caplin Point Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Caplin Point Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Caplin Point Laboratories shares is 21.37. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Caplin Point Laboratories shares is 3.94. Useful to assess the stock's value relative to its book value.

To assess Caplin Point Laboratories’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Caplin Point Laboratories is 12990.40 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Caplin Point Laboratories share price is 2395.00 & 1500.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Caplin Point Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost